Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.
King A, Rajpura J, Liang Y, Paprocki Y, Uzoigwe C. King A, et al. Among authors: paprocki y. Curr Med Res Opin. 2022 Nov;38(11):1831-1840. doi: 10.1080/03007995.2022.2125259. Epub 2022 Sep 29. Curr Med Res Opin. 2022. PMID: 36134459
The burden of severe hypoglycemia in type 2 diabetes.
Liu J, Wang R, Ganz ML, Paprocki Y, Schneider D, Weatherall J. Liu J, et al. Among authors: paprocki y. Curr Med Res Opin. 2018 Jan;34(1):179-186. doi: 10.1080/03007995.2017.1391080. Epub 2017 Nov 13. Curr Med Res Opin. 2018. PMID: 29017368
The burden of severe hypoglycemia in type 1 diabetes.
Liu J, Wang R, Ganz ML, Paprocki Y, Schneider D, Weatherall J. Liu J, et al. Among authors: paprocki y. Curr Med Res Opin. 2018 Jan;34(1):171-177. doi: 10.1080/03007995.2017.1391079. Epub 2017 Nov 10. Curr Med Res Opin. 2018. PMID: 29019269
Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE).
Tan X, Divino V, Amamoo J, Xie L, Coyle KB, Gamble CL, Guevarra M, Paprocki Y, King AA. Tan X, et al. Among authors: paprocki y. Clin Drug Investig. 2024 Apr;44(4):271-284. doi: 10.1007/s40261-024-01354-2. Epub 2024 Mar 20. Clin Drug Investig. 2024. PMID: 38507188 Free PMC article.